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 Abstract   
Objective: The aim of the study was to evaluate maternal characteristics, surgical treatment options, and morbidity 
of patients with placenta accreta.
Methods: We retrospectively reviewed the medical records of placenta accreta patients who were diagnosed and 
hospitalized between 2006 and 2010 at the Obstetrics and Gynecology Clinics of the Dicle University Hospital 
(Center A) and Maternity Hospital (Center B) in Diyarbakir, Turkey. The data were retrieved from medical charts of 
both hospitals. Maternal demographic features, clinical outcomes, type of surgical intervention, and complications 
were evaluated.
Results: The incidence of placenta accreta was 1/426 deliveries in Center A and 1/7573 deliveries in Center B 
over a 5-year period. Thirty-nine (95.1%) patients had placenta previa, and 32 (78.0%) patients had at least one 
previous cesarean delivery. Hysterectomy was performed in 28 (68.3%) of 41 women with placenta accreta and 
uterine preservation was achieved in 13 (31.7%) of them. One (2.4%) maternal death occurred. Estimated blood 
loss was >2 liters and all patients required blood products transfusion.
Conclusion: Placenta accreta is highly associated with the existence of placenta previa, especially in cases with 
previous cesarean delivery. When placenta accreta is diagnosed or suspected, the patient should be referred 
to a tertiary center for optimum care, where the obstetrical team should include experienced pelvic surgeons 
who are capable of performing emergent hysterectomy, internal iliac artery ligation, and uterine devascularization 
procedures.
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Introduction
Placenta	accreta	is	an	uncommon	but	important	complication	
of	 pregnancy	 and	 is	 associated	 with	 high	 maternal	 and	 fetal	
mortality	and	morbidity.	It	is	described	as	partial	or	total	adherence	
of	placental	 trophoblasts	 through	 the	endometrium	and	beyond	
Nitabuch’s	layer	due	to	a	defect	in	the	decidua	basalis	[1].	The	
placenta	does	not	separate	properly	from	the	uterus	after	delivery,	
which	gives	rise	to	maternal	hemorrhage.	
Risk	 factors	 include	 advanced	 maternal	 age,	 smoking,	
recurrent	abortions,	and	multiparity,	but	the	strongest	associations	
are	 with	 placenta	 previa	 and	 prior	 uterine	 surgery	 [2,	 3].	 The	
frequency	 of	 placenta	 previa	 is	 steadily	 increasing	 because	 of	
increased	numbers	of	cesarean	deliveries.	As	cesarean	deliveries	
are	 more	 commonly	 preferred,	 the	 relationship	 between	 prior	
uterine	 surgery	 and	 the	 risk	 of	 placenta	 previa	 and	 accreta	
becomes	 significant	 [4].	 Here,	 we	 present	 a	 series	 of	 placenta	
accreta	patients	who	were	managed	over	a	5-year	period.
Methods
This	 was	 a	 retrospective	 study	 of	 pregnant	 women	 with	
placenta	accreta	who	were	diagnosed	and	hospitalized	between	
January	2006	and	December	2010	at	Obstetrics	and	Gynecology	
Clinics	 of	Dicle	University	Hospital	 (Center	A)	 and	Maternity	
Hospital	(Center	B)	in	Diyarbakir,	Turkey.	
Hospital	 A	 is	 a	 tertiary	 referral	 center	 in	 the	 southeast	
Anatolian	region,	and	hospitals	in	11	cities	refer	their	complicated	
pregnancies	to	this	center.	Patients	were	identified	according	to	
information	 from	 a	 pre-existing	 clinical	 database	 and	 medical	
records.	
The	criteria	that	were	used	to	diagnose	placenta	accreta	were	
as	follows:	
1.	placenta	that	was	partially	or	totally	adherent	to	the	uterine	
wall	without	easy	separation	at	the	time	of	surgery	and	no	
cleavage	plane	between	the	placenta	and	the	uterus,	and	
2.		severe	 bleeding	 from	 the	 implantation	 site	 after	 forced	
placental	removal	during	cesarean	delivery.	
Abnormal	 placentation	 comprises	 a	 spectrum	of	 situations	
defined	as	placenta	accreta,	 increta,	 and	percreta	depending	on	
the	degree	of	 uterine	 invasion	 [5].	We	used	 the	 term	 ‘placenta	
accreta’	to	simplify	the	analysis.	With	the	exception	of	one	patient	
in	which	that	placenta	was	left	in	the	uterus	the	placentas	were	
removed	manually	at	the	time	of	the	cesarean	delivery	in	all	cases	
for	the	correct	diagnosis.	Hysterectomy	was	defined	as	subtotal	
or	total	excision	of	the	uterus.	
Conservative	treatment	was	defined	as	uterine	preservation	
as	follows:	
uterine	 devascularization	 procedure	 involving	 low	1.	
bilateral	uterine	artery	ligation	with	bilateral	utero-ovarian	
ligament	ligation;	
primary	 suturing	 by	 oversewing	 the	 placental	 bed	 after	2.	
removal	 of	 the	 placenta	 until	 hemostasis	 was	 achieved	
with	surgical	primary	sutures;	
bilateral	 internal	 iliac	 artery	 ligation	 (BIIAL),	 at	3.	
approximately	 4	 cm	 distal	 to	 the	 level	 of	 the	 common	
iliac	artery	bifurcation;	and	
the	placenta	left	entirely	within	the	uterus.	4.	
Three	 patients	 that	 were	 transferred	 to	 our	 hospital	 after	
cesarean	 delivery	 and	 two	 cases	 with	 incomplete	 data	 were	
excluded	from	the	analysis.	
The	 following	 relevant	 data	 were	 recorded:	maternal	 age,	
parity,	gestational	age,	previous	cesarean	deliveries,	and	presence	
of	placenta	previa.	
The	medical	 records	were	 also	 used	 to	 detect	 the	 type	 of	
surgical	 intervention,	 intensive	 care	 unit	 admission,	 length	 of	
hospital	stay,	estimated	amount	of	blood	loss,	and	 the	need	for	
transfusion	of	packed	red	cells.	
Maternal	 complications	 were	 also	 evaluated,	 including	
cystotomy,	coagulopathy	(platelets	of	≤100	000/µL,	international	
 Streszczenie   
Cel: Celem badania była analiza czynników matczynych, metod leczenia chirurgicznego i zachorowalności pacjen-
tek z łożyskiem wrośniętym. 
Metody: Retrospektywnie przeanalizowano historie chorób pacjentek z łożyskiem wrośniętym, które zdiagnozowano 
i leczono w latach 2006 do 2010 w Klinice Ginekologiczno-Położniczej w Dicle University Hospital (ośrodek A) 
oraz Maternity Hospital (ośrodek B) w Diyarbakir, Turcja. Dane do analizy uzyskano z dokumentacji obu szpitali. 
Oceniono czynniki matczyne, demograficzne, wyniki leczenia, rodzaj zastosowanej interwencji chirurgicznej i jej 
powikłania.
Wyniki: Częstość występowania łożyska wrośniętego wynosiła 1/426 porodów w ośrodku A i 1/7573 porodów 
w ośrodku B w okresie 5 lat obserwacji. Trzydzieści dziewięć (95,1%) pacjentek miało łożysko przodujące a 32 (78%) 
kobiety podawały co najmniej jedno cięcie cesarskie w przeszłości. Usunięcie macicy wykonano w 28 przypadkach 
(68,3%) spośród 41 kobiet z łożyskiem wrośniętym, natomiast u 13 z nich (31,7%) udało się zachować macicę. 
Jedna (2,4%) pacjentka zmarła. Szacowana utrata krwi wynosiła ponad 2 litry i wszystkie pacjentki wymagały 
przetoczeń preparatów krwi.
Wnioski: Łożysko wrośnięte jest istotnie związane z łożyskiem przodującym, zwłaszcza w przypadkach cięcia 
cesarskiego w wywiadzie. W sytuacji rozpoznania lub podejrzenia łożyska przodującego, należy przekazać pacjentkę 
do ośrodka trzeciego stopnia referencyjności celem uzyskania optymalnej opieki nad chorą. Do ośrodka, w którym 
wśród położników będą doświadczeni chirurdzy miednicy mniejszej będący w stanie wykonać natychmiastowe 
usunięcie macicy, podwiązanie tętnicy biodrowej wewnętrznej i inne procedury zmniejszające unaczynienie 
macicy.
 Słowa kluczowe:  łożysko wrośnięte / częstość występowania / leczenie chirurgiczne / 
       / cięcie cesarskie    / 
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normalized	 ratio	 of	 ≥1.2,	 and/or	 fibrinogen	 of	 ≤200mg/dL),	
occurrence	 of	 intra-abdominal	 infection,	 and	 hospital	 re-
admission	within	6	weeks.
The	 study	 protocol	 was	 approved	 by	 the	 Medical	 Ethics	
Committee	of	Dicle	University.
Data	 were	 presented	 as	 mean±standard	 deviation	 and/
or	 median	 (minimum-maximum)	 values.	 Distribution	 pattern	
of	 numerical	 data	 was	 assessed	 by	 Kolmogorov-Smirnov	 test.	
Differences	between	 the	 two	groups	were	 tested	by	Student’s	 t	
test	 for	normally	distributed	data	and	by	Mann-Whitney	U	test	
for	 skewed	 data.	 P	 value	 of	 less	 than	 0.05	 was	 accepted	 as	
statistically	significant.	
Results
During	 the	 study	 period,	 29	 placenta	 accreta	 cases	 were	
found	and	12	356	deliveries	occurred	in	Center	A,	and	12	placenta	
accreta	among	90	879	deliveries	in	Center	B.	The	incidence	of	
placenta	accreta	was	1/426.1	deliveries	in	Center	A	and	1/7573.3	
deliveries	in	Center	B	over	a	5-year	period.	The	demographic	and	
clinical	 characteristics	 of	 the	 41	 pregnancies	 complicated	with	
placenta	accreta	are	shown	in	Table	I.	
Thirty-nine	 (95.1%)	 patients	 had	 placenta	 previa,	 and	 32	
(78.0%)	had	at	least	one	previous	cesarean	delivery.	Demographics	
and	 clinical	 parameters	 with	 respect	 to	 history	 of	 cesarean	
delivery	are	presented	in	Table	2.	Maternal	age	was	found	to	be	
higher	 in	patients	without	 the	history	of	cesarean	delivery	(n	=	
9)	when	compared	with	patients	who	had	had	previous	cesarean	
delivery	(n	=	32).	There	were	no	significant	differences	in	parity,	
gestational	 age,	 amount	 of	 blood	 transfusions,	 estimated	blood	
loss,	and	postoperative	hospital	stay	days	between	women	with	
and	without	history	of	cesarean	delivery	(p>0.05),	(Table	II).	
All	patients	had	identifiable	risk	factors	for	placenta	accreta.	
Delivery	 was	 carried	 out	 by	 cesarean	 section	 in	 all	 pregnant	
women.	Fourteen	 (34.1%)	 patients	 underwent	 elective	 surgery,	
whereas	 27	 (65.9%)	 of	 them	 underwent	 emergency	 cesarean	
delivery	because	of	preterm	labor	and/or	the	presence	of	excessive	
vaginal	 bleeding.	 Hysterectomy	was	 performed	 in	 28	 (68.3%)	
out	of	41	women	with	placenta	accreta	that	were	included	in	the	
analysis,	and	conservative	treatment	was	performed	in	13	(31.7%)	
cases.	Uterine-preserving	procedures	included	oversewing	of	the	
placental	bed	(n	=	8),	uterine	devascularization	(n	=	2),	BIIAL	(n	
=	1),	ligation	of	the	utero-ovarian	ligament	plus	BIIAL	(n	=	1),	
and	whole	placenta	left	in	the	uterus	(n	=	1).	Internal	iliac	artery	
ligation	was	performed	in	8	(19.5%)	patients	(in	2	patients	without	
hysterectomy	and	in	6	with	hysterectomy	in	order	to	control	the	
hemorrhage).	Bladder	repairs	for	cystotomy	occurred	in	6	(14.6%)	
patients.	 Twelve	 (29.3%)	 women	 required	 maternal	 intensive	
care	unit	admission	including	coagulopathy	in	9,	 intraoperative	
shock	in	2,	and	respiratory	distress	plus	acute	renal	failure	in	1.	
Infectious	complications	occurred	in	7	(17.1%)	patients.	Hospital	
readmission	was	required	in	case	of	4	patients	(9.8%):	1	because	
of	wound	dehiscence	and	3	due	to	intra-abdominal	infection.	One	
(2.4%)	maternal	death	occurred	because	of	excessive	bleeding	at	
Center	B.
 
 
Table  I .  Maternal characteristics and morbidity of women with placenta accreata.
Characteristics Mean±SD Median (minimum-maximum)
Age, years 33.2±4.9 33 (22-44)
Parity, n 3.9±2.2 4 (0-9)
Gestational age, weeks 35.2±3.3 36 (24-40)
Prior cesarean sectio, n 1.5±1.2 1 (0-4)
Estimated blood loss, liters 2.43±1.2 2 (1-6)
Postopertaive length of stay, days 7.3±4.7* 6 (3-26) *
Blood transfusion, units 3.5±2.5 3 (1-14)
SD = Standard deviation, *A patient who died intraoperatively excluded.
 
 
Table  I I .  Demographics and clinical parameters of patients according to history of cesarean delivery.
Previous cesarean delivery  (n=32) No cesarean delivery  (n=9) p
Age, years 32.3±4.7 36.2±5.0 0.037
Parity, n 3.5±1.9 5.3±3.0 0.052
Gestational age, weeks 35.1±3.5 35.3±2.7 0.949
Blood transfusion, units 3.8±2.7 2.4±1.7 0.134
Estimated blood loss, liters 2.56±1.29 1.94±0.64 0.311
Postoperative hospital  stay, days 7.6±5.0 5.4±3.5 0.123
    Data are presented as mean±standard deviation. 
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Discussion 
The	 incidence	 of	 placenta	 accreta	was	 1/426	 deliveries	 in	
Center	A	and	1/7573	in	Center	B	over	the	5-year	period.	In	the	
literature,	 the	 incidence	of	placenta	accreta	varies	widely,	from	
1	in	540	to	1	in	93	000,	depending	on	differences	in	clinical	or	
histological	 definitions,	 variations	 between	 study	 groups,	 and	
different	decades	of	these	studies	[3].	Compared	with	the	literature,	
the	incidence	of	placenta	accreta	in	Center	A	was	higher;	this	was	
related	to	the	fact	that	Center	A	is	a	tertiary	University	Hospital	
where	antenatally	diagnosed	or	suspected	placenta	accreta	cases	
are	referred	to	from	other	hospitals	in	the	region.	
Miller	et	al	[6]	reported	the	following	incidences	of	abnormal	
placentation:	placenta	accreta	–	75.8%;	placenta	increta	–	17.7%;	
and	placenta	percreta	–	6.5%.	The	association	between	placenta	
accreta	and	placenta	previa	is	well	recognized,	and	the	incidence	
of	both	is	increasing	in	association	with	the	rising	rate	of	cesarean	
delivery.	In	women	with	placenta	previa	and	at	least	one	previous	
cesarean	 section,	 the	 risk	 of	 placenta	 accreta	 was	 especially	
affected	 by	 the	 location	 of	 the	 placenta	 with	 respect	 to	 the	
uterine	scar.	Placenta	accreta	occurred	in	29%	of	cases	in	which	
the	placenta	was	anteriorly	or	centrally	implanted	overlying	the	
uterine	scar	and	in	6.5%	of	cases	in	which	it	was	not.	Women	who	
had	had	two	or	more	cesarean	deliveries	with	anterior	or	central	
placenta	previa	had	nearly	a	35%	 increased	 risk	of	developing	
placenta	accreta	[6].	In	the	present	study,	32	(78.0%)	of	patients	
had	a	history	of	cesarean	delivery,	and	39	(95.1%)	had	a	history	
of	placenta	previa.	Increasing	parity,	advanced	maternal	age,	and	
prior	uterine	curettage	are	other	risk	factors	for	placenta	accreta	
[2,	3].	
Morbidity	 from	 placenta	 accreta	 is	 caused	 by	 problems	
associated	with	massive	bleeding.	In	the	present	study,	all	patients	
required	 blood	 product	 transfusion,	 and	 the	 mean	 estimated	
blood	loss	was	>2	L.	The	incidences	of	coagulopathy	requiring	
admission	to	the	intensive	care	units	and	infectious	complications	
are	also	high	in	placenta	accreta	patients,	as	reported	in	previous	
studies.	Surgical	complications	such	as	cystotomy,	ureteral	injury,	
or	the	need	for	a	second	operation	to	control	hemorrhage	could	be	
related	to	placenta	accreta	[7-9].	
Maternal	death	has	been	reported	in	up	to	7%	of	cases	[10].	
Because	 of	 the	 high	 morbidity	 and	 mortality	 associated	 with	
placenta	accreta,	a	multidisciplinary	approach	is	recommended.	
Outcomes	 could	 be	 improved	with	 an	 antenatal	 diagnosis	 and	
specialized	 care.	 Much	 consideration	 should	 be	 given	 to	 the	
management	of	massive	hemorrhage,	 including	 the	availability	
of	 packed	 cells,	 platelets,	 fresh	 frozen	 plasma,	 cryoprecipitate,	
and	whole	blood.	
Hysterectomy	 has	 traditionally	 been	 advised	 in	 the	
management	 of	 placenta	 accreta	 [11],	 but	 there	 has	 been	
a	 recent	 tendency	 toward	 conservative	 management	 for	 the	
preservation	 of	 fertility.	 Strategies	 include	 BIIAL,	 surgical	
uterine	devascularization,	resection	of	the	placental	implantation	
site,	uterine	repair,	leaving	the	placenta	in	place	after	caesarean	
delivery	 with	 medical	 treatment,	 embolization	 of	 the	 uterine	
vessels,	 uterine	 compression	 sutures,	 and/or	 oversewing	 of	 the	
placental	vascular	bed	[12-17].	In	some	cases,	hysterectomy	may	
still	fail	to	control	the	hemorrhage	and	in	these	cases	BIIAL	may	
be	added	to	the	surgical	procedure	[8].	
Although	 data	 on	 fertility	 and	 pregnancy	 outcomes	 after	
conservative	 treatment	 for	 placenta	 accreta	 are	 limited,	 a	 few	
studies	have	suggested	that	this	procedure	did	not	appear	to	have	
affected	fertility	or	subsequent	obstetrical	outcomes	[17].
This	 retrospective	study	had	some	 limitations.	The	sample	
size	 was	 insufficient	 to	 identify	 differences	 in	 complications	
with	 the	 use	 of	 different	 management	 strategies,	 fertility	
expectations	 in	 relation	 to	 the	 type	 of	 conservative	 surgery	 of	
selected	 patients,	 depth	 of	 placental	 invasion,	 surface	 width,	
and	 severity	of	bleeding.	Control	of	bleeding	differed	 in	every	
patient,	management	 decisions	were	made	 at	 the	 discretion	 of	
the	 responsible	 clinician,	 and	 standardized	 protocols	 were	 not	
employed.		
In	conclusion,	placenta	accreta	is	highly	associated	with	the	
existence	 of	 placenta	 previa,	 especially	 in	 cases	with	 previous	
cesarean	delivery.	When	placenta	accreta	is	diagnosed	or	suspected	
antenatally,	the	patient	must	be	referred	to	a	tertiary	center	in	which	
the	obstetrical	team,	comprised	of	experienced	pelvic	surgeons,	is	
capable	of	carrying	out	emergency	hysterectomy,	internal	iliac	or	
uterine	artery	ligation,	or	uterine	devascularization	procedures,	as	
well	as	dealing	with	possible	urinary	tract	injuries.
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